UCB and PAREXEL Sign Strategic Partnership Agreement

Symbols: PRXL
Posted in: News, Events
Share

PAREXEL International Corporation (NASDAQ: PRXL), today announced that it has been selected as one of two strategic partners by UCB, to provide clinical development services worldwide. PAREXEL will work with UCB to drive innovation and accelerate development, as well as to increase productivity and cost effectiveness.


 
 
< Previous
First Social Media Debuts Courtesy Of Global X
Next >
Checking In: ''A'' Shares Style
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust